Filius Bart bought PRQR

July 17, 2026 · Form 4 insider transaction

Filius Bart bought 150,000 shares of ProQR Therapeutics N.V. at $1.72 per share, a transaction worth $257.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.